⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14135002 | 1.00 | — | — | |
| SCHEMBL9272391 | 0.88 | — | — | |
| SCHEMBL14678811 | 0.71 | — | — | |
| SCHEMBL12650515 | 0.64 | — | — | |
| SCHEMBL9715235 | 0.60 | — | — | |
| SCHEMBL3767412 | 0.60 | — | — | |
| SCHEMBL16361058 | 0.60 | — | — | |
| SCHEMBL14138851 | 0.58 | — | — | |
| SCHEMBL2437075 | 0.58 | — | — | |
| SCHEMBL1490201 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3961737-B1 | COMPOSITION FOR PHOTOELECTRIC DEVICE, AND IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-10-11 | — | — | EP | disclosed |
| US-11660289-B2 | Deuterated or partially deuterated N,N-dimethyltryptamine compounds | SMALL PHARMA LTD. (GB) | 2023-05-30 | — | — | US | disclosed |
| US-11660289-B2 | Deuterated or partially deuterated N,N-dimethyltryptamine compounds | SMALL PHARMA LTD. (GB) | 2023-05-30 | — | — | US | disclosed |
| US-20230131966-A1 | FUNGICIDAL AMIDES | FMC CORPORATION | 2023-04-27 | — | — | US | disclosed |
| US-20230054458-A1 | ANTI-CLAUDIN ANTIBODY-DRUG CONJUGATE AND PHARMACEUTICAL USE THEREOF | SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) | 2023-02-23 | — | — | US | disclosed |
| US-11566003-B2 | Isoquinolines as inhibitors of HPK1 | GENENTECH, INC. (US) | 2023-01-31 | — | — | US | disclosed |
| US-20220202775-A1 | DEUTERATED OR PARTIALLY DEUTERATED N,N-DIMETHYLTRYPTAMINE COMPOUNDS | SMALL PHARMA LTD (GB) | 2022-06-30 | — | — | US | disclosed |
| US-20210163417-A1 | ISOQUINOLINES AS INHIBITORS OF HPK1 | GENENTECH, INC. (US) | 2021-06-03 | — | — | US | disclosed |
| US-10844074-B2 | Heterocycle compounds and uses thereof | Zhejiang Jianfeng-Yien Biotechnology Co., Ltd. (CN) | 2020-11-24 | — | — | US | disclosed |
| US-10577362-B2 | Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases | GENOSCIENCE PHARMA (FR) | 2020-03-03 | — | — | US | disclosed |
| WO-2009079767-A1 | INDAZOLYL, BENZIMIDAZOLYL, BENZOTRIAZOLYL SUBSTITUTED INDOLINONE DERIVATIVES AS KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER | UNIVERSITY HEALTH NETWORK (CA) | 2009-07-02 | — | — | WO | disclosed |
| WO-2009015485-A1 | CYCLIC INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER | UNIVERSITY HEALTH NETWORK (CA) | 2009-02-05 | — | — | WO | disclosed |
| WO-2008150486-A2 | 2-ACYLAMINOPROPOANOL-TYPE GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | GENZYME CORPORATION (US) | 2008-12-11 | — | — | WO | disclosed |
| US-20080234334-A1 | 1,4 DIAMINO BICYCLIC RETIGABINE ANALOGUES AS POTASSIUM CHANNEL MODULATORS | VALEANT PHARMACEUTICALS INTERNATIONAL (US) | 2008-09-25 | — | — | US | disclosed |
| WO-2008109991-A1 | INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER | UNIVERSITY HEALTH NETWORK (CA) | 2008-09-18 | — | — | WO | disclosed |
| WO-2003011115-A2 | PEPTIDE-BASED MULTIMERIC TARGETED CONTRAST AGENTS | EPIX MEDICAL, INC. (US) | 2003-02-13 | — | — | WO | disclosed |
| JP-2001220379-A | METHOD FOR PRODUCING 3a,7a-DIHYDROINDOLE COMPLEX | SUMITOMO CHEM CO LTD | 2001-08-14 | — | — | JP | disclosed |
| EP-0327426-B1 | Indolo[3,2,1-de][1,4]-oxazino[2,3,4-ij][1,5]naphthyridine derivatives, process for their preparation and intermediates, their use as medicaments and compositions containing them | ROUSSEL UCLAF (FR) | 1993-11-03 | — | — | EP | disclosed |
| US-4904655-A | Novel indolo [3,2,1-de] [1,4] oxazino [2,3,4-ij] [1,5] | ROUSSEL UCLAF (FR) | 1990-02-27 | — | — | US | disclosed |
| EP-0327426-A1 | Indolo[3,2,1-de][1,4]-oxazino[2,3,4-ij][1,5]naphthyridine derivatives, process for their preparation and intermediates, their use as medicaments and compositions containing them | ROUSSEL-UCLAF (FR) | 1989-08-09 | — | — | EP | disclosed |